StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | BIIB Biogen | $188.01 | -2.20% | $28.5B | 20.8 | 2.9 | +1.2% | 75.5% | 41 |
| 1 | MRNA Moderna | $45.19 | -1.89% | $18.3B | — | 8.2 | -30.0% | 35.0% | 59 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $101.19 |
| -4.56% |
| $22.5B |
| — |
| 27.5 |
| +115.1% |
| 81.8% |
| 55 |
| 3 | ALNY Alnylam Pharmaceuticals | $285.61 | -3.39% | $40.4B | 70.0 | 9.4 | +82.6% | 80.8% | 46 |
| 4 | INCY Incyte | $93.81 | -1.86% | $19.0B | 13.3 | 3.5 | +21.5% | 93.0% | 46 |
| 5 | NTRA Natera | $213.93 | -2.23% | $31.5B | — | 12.6 | +36.6% | 65.1% | 46 |
| 6 | REGN Regeneron | $594.51 | -1.02% | $61.3B | 13.9 | 4.1 | +5.9% | 85.7% | 43 |
| 7 | UTHR United Therapeutics | $535.20 | -1.73% | $23.1B | 18.0 | 7.3 | +5.9% | 86.6% | 37 |
| 8 | 950200.KQ 950200.KQ | — | — | — | — | — | — | — | — |
| 9 | RVMD RVMD | $154.30 | -5.73% | $34.8B | — | 3007.1 | — | — | — |